Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Metabolic Imaging of Patients With Lower Grade Glioma Using Hyperpolarized 13C Pyruvate

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04540107
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:59.804068+00:00
Published At
2025-01-10T00:00:00+00:00
Record Updated At
2025-01-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent World Health Organization (WHO) Grade II Glioma", "Recurrent WHO Grade III Glioma", "WHO Grade II Glioma", "WHO Grade III Glioma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-01-10"
protocolSection.identificationModule.nctId
"NCT04540107"
protocolSection.identificationModule.officialTitle
"Metabolic Imaging of Patients With Lower Grade Glioma Using Hyperpolarized 13C Pyruvate"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Recurrent World Health Organization (WHO) Grade II Glioma (protocolSection.conditionsModule.conditions)
  • Recurrent WHO Grade III Glioma (protocolSection.conditionsModule.conditions)
  • WHO Grade II Glioma (protocolSection.conditionsModule.conditions)
  • WHO Grade III Glioma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.